BRCA1 and ovarian cancer: It has been shown to be associated with a lower risk of ovarian cancer, a lower risk of breast cancer, lower all-cause mortality, breast cancer-specific mortality, and ovarian cancer-specific mortality in BRCA1/2 mutation carriers.